Dentsply Sirona (NASDAQ: XRAY) net income
Dentsply Sirona reported a net loss of $598.0m for fiscal 2025; in fiscal 2024 it reported a net loss of $910.0m. Earnings per share were −$3.00.
Dentsply Sirona's best year of the last 10 was fiscal 2016. It reported a loss in 7 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$598.0m | — | −16.3% | −$3.00 |
| 2024 | −$910.0m | — | −24.0% | −$4.48 |
| 2023 | −$132.0m | — | −3.3% | −$0.62 |
| 2022 | −$950.0m | −331.1% | −24.2% | −$4.41 |
| 2021 | $411.0m | — | 9.7% | $1.93 |
| 2020 | −$73.0m | −128.5% | −2.2% | −$0.33 |
| 2019 | $256.0m | — | 6.4% | $1.18 |
| 2018 | −$1,011m | — | −25.4% | −$4.51 |
| 2017 | −$1,550m | −460.5% | −38.8% | −$6.76 |
| 2016 | $429.9m | — | 11.5% | $1.97 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Dentsply Sirona net income compared with its sector
By net income for its latest fiscal year, Dentsply Sirona ranks 481st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Dentsply Sirona, −16.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 479th | Ultragenyx Pharmaceutical | −$575.0m | −85.4% |
| 480th | Crispr Therapeutics AG | −$581.6m | −16,569.8% |
| 481st | Dentsply Sirona | −$598.0m | −16.3% |
| 482nd | Recursion Pharmaceuticals | −$644.8m | −863.4% |
| 483rd | Vor Biopharma | −$696.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Dentsply Sirona
- How much did Dentsply Sirona earn in fiscal 2025?
- Dentsply Sirona reported a net loss of $598.0m for fiscal 2025. In fiscal 2024 it reported a net loss of $910.0m.
- What are the earnings per share of Dentsply Sirona?
- They were −$3.00 in fiscal 2025, compared with −$4.48 in fiscal 2024.
- What was the most profitable year for Dentsply Sirona?
- Of its last 10 fiscal years, fiscal 2016, with $429.9m.
- Where does Dentsply Sirona rank in its sector by net income?
- It ranks 481st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Dentsply Sirona come from?
- From the annual report (Form 10-K) that Dentsply Sirona files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Dentsply Sirona files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Dentsply Sirona: the Dentsply Sirona page · annual accounts · revenue · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.